Investment
Features
FeesSafety
Academy
More
Pluang+

Insmed's Brinsupri hits $517M sales; strong pipeline boosts Buy rating despite high valuation.

Analyst Insights
22 Sep 2026
Seeking Alpha
View Source
Bullish
Insmed's Brinsupri hits $517M sales; strong pipeline boosts Buy rating despite high valuation.

Insmed's Brinsupri drug generated $517 million in sales in the first half of 2026, showing strong market demand with minimal competition. The company targets over $7 billion in peak sales, especially benefiting from COPD and asthma comorbidity markets. Additionally, Insmed's TPIP drug showed better-than-expected Phase 2b trial results, with four potential Phase 3 indications that could exceed $6 billion in peak sales if approved. Despite a high price-to-sales ratio and some competitive risks, the early sales success and promising pipeline support a positive long-term investment outlook for Insmed.

Insmed's recent performance is contextually framed by Pluang's Health sector data. For readers following health stocks, here is Pluang's market snapshot as of Sep 22, 2026 22:01 WIB: Out of 101 priced US health stocks, 71 gained and 29 declined. Notable movers include XRAY at USD 9.87 (+4.56%), BNTX at USD 102.00 (+4.08%) with 100% buy order activity, and ACHC at USD 29.48 (+3.91%).

More News

MillerKnoll beats profit estimates with $0.53 EPS despite revenue decline in Q1 2027.

MillerKnoll beats profit estimates with $0.53 EPS despite revenue decline in Q1 2027.

MillerKnoll reported a strong Q1 2027 earnings per share (EPS) of $0.53, surpassing analyst expectations by over 51%, helped by tariff refunds and improved cost management. However, its revenue fell 3.4% year-over-year to $923.40 million, missing est...

Company Fundamentals
Neutral
2 hours ago
THOR Industries misses Q4 EPS estimates but beats revenue expectations amid RV market challenges

THOR Industries misses Q4 EPS estimates but beats revenue expectations amid RV market challenges

THOR Industries reported Q4 earnings with an EPS of $0.78, missing analyst estimates and showing a 66.9% drop from last year. Despite this, the company beat revenue expectations with $2.31 billion, though revenue declined 8.4% year-over-year due to w...

Company Fundamentals
Bearish
3 hours ago
Cracker Barrel earnings expected to drop sharply in Q3 2026, with EPS forecast at $0.17 and revenue down.

Cracker Barrel earnings expected to drop sharply in Q3 2026, with EPS forecast at $0.17 and revenue down.

Cracker Barrel Old Country Store is set to report its Q3 2026 earnings on September 23, with analysts predicting a significant decline. Earnings per share are expected to fall to $0.17 from $0.74 last year, and revenue is forecasted around $834.57 mi...

Company Fundamentals
Bearish
3 hours ago
Salesforce's AI business grows rapidly, stock seen undervalued with 39% upside potential.

Salesforce's AI business grows rapidly, stock seen undervalued with 39% upside potential.

Salesforce's AI-driven Agentforce business is expanding at over 240% annual recurring revenue growth, yet its stock trades like a legacy CRM company, down 9.6% year-to-date. The company reported strong Q2 FY27 results with $11.35 billion revenue and ...

Market News
Bullish
4 hours ago
Health Net aids Californians with emergency services amid state disaster declarations.

Health Net aids Californians with emergency services amid state disaster declarations.

Health Net, a Medi-Cal managed care plan in California, is providing emergency support following Gov. Newsom's statewide State of Emergency declaration due to severe weather and a sewage spill. The company is helping members access emergency medicati...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App